In commemoration of the 2023 World Hemophilia Day, Pfizer has reiterated its commitment to hemophilia awareness in promoting the need for innovation in access to treatments for people living with the condition.
“Pfizer’s efforts at advancing treatment for hemophilia and bridge gaps in access
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
Seyi John Salau
Seyi John Salau is a BusinessDay Correspondent with interest in development journalism, which tells stories that connect the people, brands, and the government. SeyiJohn is also a media professional with BSc, Mass Communition (ACU); Masters of School Media (MSM, Ibadan) & MSc, Mass Communication (Caleb).
